about
msbB deletion confers acute sensitivity to CO2 in Salmonella enterica serovar Typhimurium that can be suppressed by a loss-of-function mutation in zwfExtragenic suppressors of growth defects in msbB Salmonella.The role of parasites in generating evolutionary novelty.pmrA(Con) confers pmrHFIJKL-dependent EGTA and polymyxin resistance on msbB Salmonella by decorating lipid A with phosphoethanolamine.Cloning of a cDNA encoding the dense granule protein GRA3 from Toxoplasma gondii.EGFR-targeted Chimeras of Pseudomonas ToxA released into the extracellular milieu by attenuated Salmonella selectively kill tumor cells.Fungi in neotropical epiphyte roots.A culture-based method for determining the production of secreted protease inhibitors.Drug ratio-dependent antitumor activity of irinotecan and cisplatin combinations in vitro and in vivo.In vivo maintenance of synergistic cytarabine:daunorubicin ratios greatly enhances therapeutic efficacy.Attenuated Salmonella targets prodrug activating enzyme carboxypeptidase G2 to mouse melanoma and human breast and colon carcinomas for effective suicide gene therapy.Modulating the therapeutic activity of nanoparticle delivered paclitaxel by manipulating the hydrophobicity of prodrug conjugates.Structure and function of the Toxoplasma gondii vacuole.Kinetics and pattern of organelle exocytosis during Toxoplasma gondii/host-cell interaction.Accumulation of single-stranded DNA in Escherichia coli carrying the colicin plasmid pColE3-CA38Melanoma x macrophage hybrids with enhanced metastatic potential.Leukemia-selective uptake and cytotoxicity of CPX-351, a synergistic fixed-ratio cytarabine:daunorubicin formulation, in bone marrow xenografts.Salmonella-based tumor-targeted cancer therapy: tumor amplified protein expression therapy (TAPET) for diagnostic imaging.Tumor-targeted Salmonella expressing cytosine deaminase as an anticancer agent.Tumor-targeted Salmonella typhimurium overexpressing cytosine deaminase: a novel, tumor-selective therapy.Isolation and Analysis of Suppressor Mutations in Tumor-Targeted msbB Salmonella.In vitro antagonism of bioluminescent fungi by Trichoderma harzianum
P50
Q33494726-EB1555A3-4922-4702-8B2E-B536252D86EFQ33996895-469B453D-07AA-4D59-8914-DAFC8281BC30Q35908177-14B0DB89-A4B3-4CC1-8DE6-591840D4F4A3Q35949418-468B8F16-3AD4-4669-8C4A-A0C3DF1F24D8Q36702760-610084BA-B86D-4792-986F-4E7F048F7807Q37372414-EDF2A87B-1DB4-477B-ADA6-9E35977BE027Q38905630-D103173A-1DCC-43AF-95B4-69A01F3E21D3Q39176108-253B02B3-3C12-4086-BB58-3B0B438D475AQ39813841-2E9CAE24-8FD9-47BC-BA20-3BDCCF59A3AFQ39954638-9CC8FC75-47A1-4BC6-A0E4-1BCD8C5689E4Q39966345-EBF196B8-D634-4348-9F62-CB3B716BC77DQ39984316-9F358A3A-A2D6-4DB8-92FA-B5ECD4BBF1E0Q41307146-A8D79A6C-0890-4268-B078-4A7B49DE6321Q41582214-B1F8A289-3CDF-49DC-8C5D-16A268CA4A2AQ41754523-885E4B36-E755-461F-AAD3-88BBA1A86919Q42456649-6733710E-AE0B-47B3-8708-1C743E8B9080Q43170366-6CE895D6-F8CB-4C49-AC91-7FEE1532454BQ43698668-F4860AFA-B7EF-4782-8EFF-7C7D5E5E2507Q44073787-74F2FFC8-5E01-4107-A7FF-1EF93FE9A680Q45946592-8499C7EA-2AB1-4296-A927-62C8F80369A2Q46108228-A1FB97EA-A5A0-412E-BCB3-D3A5B3CFBD2AQ58787852-75A5921B-CA7E-4A49-A65D-4309586294BD
P50
description
Forscher
@de
chercheur
@fr
investigador
@es
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
研究者
@zh
name
David Bermudes
@ast
David Bermudes
@en
David Bermudes
@es
David Bermudes
@nl
type
label
David Bermudes
@ast
David Bermudes
@en
David Bermudes
@es
David Bermudes
@nl
prefLabel
David Bermudes
@ast
David Bermudes
@en
David Bermudes
@es
David Bermudes
@nl
P106
P1153
7004076479
P21
P31
P496
0000-0003-1910-3192